Home > Insider Trading > Filing (0000899243-23-011231)

Filing Details

Accession Number:: 0000899243-23-011231
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-04-12 21:44:09
Reporting Period:: 2023-04-10

Accepted Time:: 2023-04-12 21:44:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1832415	Better Therapeutics Inc.	BTTX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1105941	P David Perry	C/O Better Therapeutics, Inc. 548 Market Street, #49404 San Francisco CA 94104	See Remarks	Yes	Yes	Yes	No
1890678	Trust 2015 Perry P. David	C/O Better Therapeutics, Inc. 548 Market Street, #49404 San Francisco CA 94104		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-04-10	1,333,333	$0.83	11,797,348	No	4	P	Indirect	By Perry Trust
Common Stock	Acquisiton	2023-04-10	3,636,364	$0.83	3,636,364	No	4	P	Indirect	By Maule-Ffinch Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Perry Trust
No	4	P	Indirect	By Maule-Ffinch Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	293,150	Indirect	By spouse
Common Stock	21,336	Indirect	By Pensus Limited Trust
Common Stock	101,536	Direct

Footnotes

On April 6, 2023, the Issuer entered into a Securities Purchase Agreement with certain investors (the "PIPE Investors") in a private placement offering, pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $0.825 per share.
As one of the PIPE Investors, the David P. Perry 2015 Trust (the "Perry Trust") acquired 1,333,333 shares of Issuer common stock on April 10, 2023 for $0.825 per share.
These shares are owned directly by the Perry Trust, a ten percent owner of the Issuer, and indirectly by David P. Perry ("Perry") as trustee of the Perry Trust. Perry is an officer, director and ten percent owner of the Issuer.
As one of the PIPE Investors, the Georgianna Maule-Ffinch 2015 Trust (the "Maule-Ffinch Trust") acquired 3,636,364 shares of Issuer common stock on April 10, 2023 for $0.825 per share.
These shares are owned directly by the Maule-Ffinch Trust, a ten percent owner of the Issuer, and indirectly by Perry's spouse, Georgianna Maule-Ffinch ("Maule-Ffinch"), as the sole trustee of the Maule-Ffinch Trust, for the benefit of Maule-Ffinch and her children. Perry disclaims beneficial ownership of these securities, and the filing of this Form 4 is not an admission that Perry is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
These shares are owned directly by Maule-Ffinch.
These shares are owned directly by Donald R. Leo, Trustee of Pensus Limited Trust dated 06/12/2010 FBO Georgianna Maule-Ffinch (the "Pensus Limited Trust") for the benefit of Maule-Ffinch. Perry disclaims beneficial ownership of these securities, and the filing of this Form 4 is not an admission that Perry is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.